Track topics on Twitter Track topics that are important to you
Algeta ASA is a cancer therapeutics company built on world-leading, proprietary technology. Algeta is developing a new generation of targeted cancer therapeutics (alpha-pharmaceuticals) that harness the unique characteristics of alpha particle emitters and are potent, well-tolerated and convenient to use.
RICHMOND, Calif., May 2, 2013 /PRNewswire/ -- Lumiphore, Inc., a biotechnology leader in new proprietary bi-functional metal-chelation technology for use in targeted radiopharmaceuticals h...
WAYNE, N.J., Feb. 2, 2012 /PRNewswire/ -- Bayer HealthCare, LLC today announced that the U.S. Food and Drug Administration agreed that Bayer can proceed with its expanded access program ...
Algeta ASA is a cancer therapeutics company built on world-leading, proprietary technology. Algeta is developing a new generation of targeted cancer therapeutics (alpha-pharmaceuticals) that harne...
Algeta was founded in 1997 (as Anticancer Therapeutic Inventions) based upon a unique combination of radiation chemistry, nuclear medicine and clinical oncology expertise brought together by its two...
We have published hundreds of Algeta news stories on BioPortfolio along with dozens of Algeta Clinical Trials and PubMed Articles about Algeta for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Algeta Companies in our database. You can also find out about relevant Algeta Drugs and Medications on this site too.
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...